The market for palliative care in advanced solid tumors is witnessing substantial growth as the prevalence of these malignancies continues to increase. The market is driven by the recognition of the significant symptom burden and complex care needs experienced by patients with advanced solid tumors, such as lung, breast, colorectal, and pancreatic cancers. Palliative care services that focus on pain management, symptom control, psychosocial support, and end-of-life care are in high demand. The integration of palliative care into the overall treatment plans for advanced solid tumors is gaining traction. However, challenges including limited access to palliative care resources, variations in healthcare systems, and the need for enhanced education and training for healthcare professionals exist. The market for palliative care in advanced solid tumors is expected to continue expanding as healthcare providers prioritize comprehensive and patient-centered care for individuals facing these challenging conditions.
All accepted abstracts will be published in respective Allied Academies Journals.
Abstracts will be provided with Digital Object Identifier by
